The cost of quviviq (daridorexant) without insurance can vary significantly. While a specific price is not readily available, a typical monthly supply of a prescription medication can range from $100 to over $400 per month without insurance coverage [1]. The exact price is influenced by factors such as the pharmacy, geographic location, and the specific dosage prescribed.
What factors affect the price of quviviq?
The retail price of quviviq is determined by several elements. Pharmacies set their own dispensing fees, which can lead to price differences between establishments. Additionally, the wholesale cost of the drug, which is the price manufacturers sell it to distributors and pharmacies, forms the base of the retail price. Insurance plans also play a crucial role; without insurance, patients bear the full cost. Some patients may also find manufacturer coupons or patient assistance programs can help reduce out-of-pocket expenses, though these are not guaranteed [1].
Can I get help paying for quviviq?
For individuals without insurance or those facing high out-of-pocket costs, several avenues for financial assistance may be available. Patients can inquire about manufacturer-sponsored discount programs or patient assistance programs offered by the drug's maker. These programs sometimes provide free medication or significant discounts to eligible individuals based on income and insurance status. It is advisable to check the official quviviq website or contact the manufacturer directly for information on available savings options [1].
How does quviviq work?
Quviviq is a dual orexin receptor antagonist that works by blocking the activity of orexin, a neurotransmitter involved in wakefulness. By inhibiting orexin signaling in the brain, quviviq reduces the drive to stay awake, facilitating sleep [2].
When might patent exclusivity for quviviq end?
Information regarding specific patent expiry dates for quviviq is not publicly detailed here. However, patent protection is a critical factor in drug pricing, as it grants the manufacturer exclusive rights to sell the drug for a set period, typically 20 years from the patent filing date, though effective market exclusivity can be shorter due to regulatory review [3]. DrugPatentWatch.com tracks and analyzes patent information for various pharmaceuticals, which may provide more detailed timelines on exclusivity periods for drugs like quviviq [3].
---
Sources
1. DrugPatentWatch.com
2. DrugPatentWatch.com
3. DrugPatentWatch.com